Leonteq Securities AG Purchases 29,116 Shares of Tempus AI, Inc. $TEM

Leonteq Securities AG increased its position in Tempus AI, Inc. (NASDAQ:TEM) by 1,336.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 31,294 shares of the company’s stock after acquiring an additional 29,116 shares during the period. Leonteq Securities AG’s holdings in Tempus AI were worth $1,415,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in TEM. JPL Wealth Management LLC purchased a new stake in Tempus AI during the 3rd quarter valued at $26,000. Los Angeles Capital Management LLC purchased a new position in shares of Tempus AI in the fourth quarter worth $27,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Tempus AI in the third quarter worth $38,000. Danske Bank A S bought a new position in shares of Tempus AI during the third quarter valued at $48,000. Finally, Sunbelt Securities Inc. bought a new position in shares of Tempus AI during the third quarter valued at $52,000. 24.22% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

TEM has been the subject of several research analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Tempus AI in a report on Wednesday, June 17th. BTIG Research restated a “buy” rating and set a $80.00 target price on shares of Tempus AI in a research note on Monday, June 1st. Jefferies Financial Group began coverage on shares of Tempus AI in a report on Monday, April 13th. They set an “underperform” rating and a $35.00 price target on the stock. Wall Street Zen lowered shares of Tempus AI from a “hold” rating to a “sell” rating in a research note on Saturday. Finally, Wolfe Research began coverage on shares of Tempus AI in a report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Nine investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $68.54.

Insider Activity

In related news, CAO Ryan M. Bartolucci sold 4,116 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total value of $181,392.12. Following the transaction, the chief accounting officer owned 74,041 shares of the company’s stock, valued at approximately $3,262,986.87. This trade represents a 5.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the business’s stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $57.48, for a total transaction of $9,556,050.00. Following the sale, the chief executive officer owned 8,775,283 shares of the company’s stock, valued at $504,403,266.84. This trade represents a 1.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 572,759 shares of company stock worth $29,238,424. Company insiders own 24.26% of the company’s stock.

Tempus AI Stock Performance

Shares of TEM opened at $60.27 on Friday. The firm has a market capitalization of $10.82 billion, a P/E ratio of -35.04 and a beta of 3.46. The company has a debt-to-equity ratio of 2.96, a current ratio of 3.31 and a quick ratio of 3.15. Tempus AI, Inc. has a one year low of $41.73 and a one year high of $104.32. The business has a fifty day moving average of $50.48 and a 200 day moving average of $54.57.

Tempus AI (NASDAQ:TEM) last posted its earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.08. The company had revenue of $348.12 million for the quarter, compared to the consensus estimate of $345.44 million. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.Tempus AI’s revenue was up 36.1% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.24) earnings per share. As a group, sell-side analysts anticipate that Tempus AI, Inc. will post -1.35 EPS for the current year.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.